1Langendam M, Luijf YM, Hooft L, et al. Continuous glucose monito- ring systems for type 1 diabetes mellitus [ J ]. Cochrane Database Syst Rev,2012,1 : CD008101.
2Lachin JM, Genuth S, Nathan DM, et al. Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial- revisited[ J]. Diabetes,2008,57(4) :995 -1001.
3Jiao XM, Zhang XG, Xu XU, et al. Blood glucose fluctuation aggra- vates lower extremity vascular disease in type 2 diabetes [ J]. Eur Rev Med Pharmacol Sci,2014,18 (14) :2025 - 2030.
4Zhang XG, Zhang YQ, Zhao DK, et al. Relationship between blood glucose fluctuation and maerovascular endothelial dysfunction in type 2 diabetic patients with coronary heart disease[ J]. Eur Rev Med Pharma- col Sci, 2014,18(23) :3593 -600.
5Kusunoki Y, Katsnno T, Nakae R, et al. Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self- monitoring of blood glucose and continuous glucose monitoring[J]. Dia- betes Res Clin Pract,2015,108 (2) :342 - 349.
6Huang J, Zhang X, Li J, et al. Impact of glucose fluctuation on acute cerebral infarction in type 2 diabetes [ J ]. Can J Neural Sci, 2014,41 (4) :486-492.
7Dobbs MR, Krishnamohan P, Jicha G, et al. Innovation in Stroke Care Quality: NIH Stroke Scale Change and Shewhart Charts[J]. Qual Man- ag Health Care,2015,24 ( 3 ) : 135 - 139.
